Header Logo

Connection

Bethany Hannafon to Docosahexaenoic Acids

This is a "connection" page, showing publications Bethany Hannafon has written about Docosahexaenoic Acids.
Connection Strength

0.846
  1. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 2015 Jul 16; 14:133.
    View in: PubMed
    Score: 0.464
  2. Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. BMC Cancer. 2018 Oct 26; 18(1):1042.
    View in: PubMed
    Score: 0.146
  3. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions. Oncotarget. 2017 Mar 14; 8(11):17908-17920.
    View in: PubMed
    Score: 0.130
  4. Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation. J Nutr Biochem. 2014 May; 25(5):515-25.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.